Vivek Singh

We are building a multimodal AI platform to revolutionise liver cancer care by enabling earlier, more accurate detection of recurrences.

Problem

Today, liver cancer recurrence is often detected too late. Conventional imaging frequently misses very early-stage tumors, especially sub-5 mm lesions, leaving patients with fewer treatment options and worse outcomes. This critical gap in early detection prevents clinicians from intervening when therapies are most effective; directly impacting survival and quality of life.

Solution 

Our multimodal AI system is designed to detect liver cancer recurrences at the earliest possible stage including sub-5 mm lesions that are often overlooked in routine reporting. By integrating advanced imaging analysis with clinical data, our technology empowers clinicians with greater accuracy, speed and confidence in diagnosis, enabling earlier interventions and improving patient outcomes.

Contact

Vivek Singh